Armistice Capital, LLC 13D/13G Filings for Entero Therapeutics, Inc. (ENTO)

Armistice Capital, LLC 13D and 13G filings for Entero Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-14
2:45 pm
Purchase
2023-12-3113GENTERO THERAPEUTICS INC
ENTO
Armistice Capital, LLC26,020
4.990%
13,680increase
(+110.86%)
Filing